The Unlikely Catalyst for a Breakthrough in Mental Health Treatment The news of President Trump's support for psychedelic treatments has sent ripples through the medical community, prompting Rep. Jack Bergman (R Mich.
) to seize on this momentum and push for further research as co founder and co chair of Congressional Psychedelics Advancing Therapies (PATH).
Bergman's enthusiasm is understandable, but what does this development really mean for the future of mental health treatment?